Adverse events, healthcare interventions and healthcare utilization during home infusion therapy with daptomycin and vancomycin: A propensity score-matched cohort study

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 5, 2014, Pages 1407-1415

  Shrestha, Nabin K ^a   Mason, Pamela ^a   Gordon, Steven M ^a   Neuner, Elizabeth ^a   Nutter, Benjamin ^a   O'Rourke, Colin ^a   Rehm, Susan J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Adverse reactions; Antibiotic usage; Antimicrobial therapy; Drug monitoring; Lipopeptides; OPAT

Indexed keywords

CREATINE KINASE; DAPTOMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ABDOMINAL INFECTION; ABNORMAL LABORATORY RESULT; ABSCESS; ACUTE KIDNEY FAILURE; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BONE INFECTION; CATHETER INFECTION; CENTRAL NERVOUS SYSTEM INFECTION; COMPARATIVE STUDY; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DEEP NONVISCERAL ABSCESS; DEVICE INFECTION; DISEASE EXACERBATION; DRUG ERUPTION; DRUG INDUCED DISEASE; DRUG MONITORING; DRUG WITHDRAWAL; ENDOCARDITIS; ENTEROCOCCAL INFECTION; EOSINOPHILIA; FEMALE; GASTROINTESTINAL DISEASE; HEALTH CARE UTILIZATION; HOME CARE; HOSPITAL READMISSION; HUMAN; INFECTIOUS ARTHRITIS; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTPATIENT CARE; OUTPATIENT PARENTERAL ANTIMICROBIAL THERAPY; PROPENSITY SCORE; PRURITUS; RETROSPECTIVE STUDY; SIDE EFFECT; SKIN INFECTION; STAPHYLOCOCCUS INFECTION; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; URINARY TRACT INFECTION; AGED; BACTERIAL INFECTIONS; COHORT ANALYSIS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HEALTH CARE FACILITY; INFUSION; UTILIZATION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; COHORT STUDIES; DAPTOMYCIN; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HEALTH FACILITIES; HOME INFUSION THERAPY; HUMANS; MALE; MIDDLE AGED; PROPENSITY SCORE; RETROSPECTIVE STUDIES; VANCOMYCIN;

EID: 84898446682     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt512     Document Type: Article

References (20)

1. Williams DN, Rehm SJ, Tice AD et al. Practice guidelines for community-based parenteral anti-infective therapy. ISDA Practice Guidelines Committee. Clin Infect Dis 1997; 25: 787-801.
2. Tice AD, Rehm SJ, Dalovisio JR et al. Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin Infect Dis 2004; 38: 1651-72.
3. Chapman ALN, Seaton RA, Cooper MA et al. Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement. J Antimicrob Chemother 2012; 67: 1053-62.
4. Fowler VG Jr, Boucher HW, Corey GR et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006; 355: 653-65.
5. Moore CL, Osaki-Kiyan P, Haque NZ et al. Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study. Clin Infect Dis 2012; 54: 51-8.
6. Murray KP, Zhao JJ, Davis SL et al. Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration .1 mg/L: a matched cohort study. Clin Infect Dis 2013; 56: 1562-9.
7. Hair PI, Keam SJ. Daptomycin: a review of its use in the management of complicated skin and soft-tissue infections and Staphylococcus aureus bacteraemia. Drugs 2007; 67: 1483-512.
8. Arbeit RD, Maki D, Tally FP et al. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin Infect Dis 2004; 38: 1673-81.
9. Pertel PE, Eisenstein BI, Link AS et al. The efficacy and safety of daptomycin vs. vancomycin for the treatment of cellulitis and erysipelas. Int J Clin Pract 2009; 63: 368-75.
10. Lipsky BA, Stoutenburgh U. Daptomycin for treating infected diabetic foot ulcers: evidence from a randomized, controlled trial comparing daptomycin with vancomycin or semi-synthetic penicillins for complicated skin and skin-structure infections. J Antimicrob Chemother 2005; 55: 240-5.
11. Gordon SM, Shrestha NK, Rehm SJ. Transitioning antimicrobial stewardship beyond the hospital: the Cleveland Clinic's communitybased parenteral anti-infective therapy (CoPAT) program. J Hosp Med 2011; 6 Suppl 1: S24-30.
12. National Institutes of Allergy and Infectious Diseases. Table for Grading the Severity of Adult and Pediatric Adverse Events. Regulatory Compliance Center of the Division of AIDS of the National Institute of Allergy and Infectious Diseases, 2004.
13. Bellomo R, Ronco C, Kellum JA et al. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-12.
14. van Buuren S, Groothius-Oudshoorn K. mice: Multivariate imputation by chained equations in R. J Stat Softw 2011; 45: 1-67.
15. Mitra R, Reiter JP. A comparison of two methods of estimating propensity scores after multiple imputation. Stat Methods Med Res 2012; doi:10.1177/0962280212445945.
16. Sekhon JS. Multivariate and propensity score matching with automated balance optimization: the matching package for R. J Stat Softw 2011; 42: 1-52.
17. Rubin DB. Multiple Imputation for Non-Response in Surveys. New York: J. Wiley & Sons, 1987.
18. Hoffman-Terry ML, Fraimow HS, Fox TR et al. Adverse effects of outpatient parenteral antibiotic therapy. Am J Med 1999; 106: 44-9.
19. Rehm SJ, Longworth DL. Rates of adverse events associated with community-based parenteral anti-infective therapy. J Clin Outcome Manage 2000; 7: 23-8.
20. Barr DA, Semple L, Seaton RA et al. Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years. Int J Antimicrob Agents 2012; 39: 407-13.